Identification of Carboxylesterase-Dependent Dabigatran Etexilate Hydrolysis s

Dabigatran etexilate (DABE) is an oral prodrug that is rapidly converted to the active thrombin inhibitor, dabigatran (DAB), by serine esterases. The aims of the present study were to investigate the in vitro kinetics and pathway of DABE hydrolysis by human carboxylesterase enzymes, and the effect of alcohol on these transformations. The kinetics of DABE hydrolysis in two human recombinant carboxylesterase enzymes (CES1 and CES2) and in human intestinal microsomes and human liver S9 fractions were determined. The effects of alcohol (a known CES1 inhibitor) on the formation of DABE metabolites in carboxylesterase enzymes and human liver S9 fractions were also examined. The inhibitory effect of bis(4-nitrophenyl) phosphate on the carboxylesterase-mediated metabolism of DABE and the effect of alcohol on the hydrolysis of a classic carboxylesterase substrate (cocaine) were studied to validate the in vitro model. The ethyl ester of DABE was hydrolyzed exclusively by CES1 to M1 ( K m 24.9 6 2.9 m M, V max 676 6 26 pmol/min per milligram protein) and the carbamate ester of DABE was exclusively hydrolyzed by CES2 to M2 ( K m 5.5 6 0.8 m M; V max 71.1 6 2.4 pmol/min per milligram protein). Sequential hydrolysis of DABE in human intestinal microsomes followed by hydrolysis in human liver S9 fractions resulted in complete conversion to DAB. These results suggest that after oral administration of DABE to humans, DABE is hydrolyzed by intestinal CES2 to the intermediate M2 metabolite followed by hydrolysis of M2 to DAB in the liver by CES1. Carboxylesterase-mediated hydrolysis of DABE was not inhibited by alcohol.

[1]  V. Herring,et al.  The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance? , 2013, Pharmacotherapy.

[2]  Y. Peterson,et al.  Prediction and In Vitro Evaluation of Selected Protease Inhibitor Antiviral Drugs as Inhibitors of Carboxylesterase 1: A Potential Source of Drug-Drug Interactions , 2012, Pharmaceutical Research.

[3]  E. Merriman,et al.  Bleeding risk with dabigatran in the frail elderly. , 2012, The New England journal of medicine.

[4]  Wei Niu,et al.  Accurate determination of the anticancer prodrug simmitecan and its active metabolite chimmitecan in various plasma samples based on immediate deactivation of blood carboxylesterases. , 2011, Journal of chromatography. A.

[5]  K. Patrick,et al.  Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations. , 2011, Journal of pharmaceutical sciences.

[6]  Kayoko Ohura,et al.  The role of intestinal carboxylesterase in the oral absorption of prodrugs. , 2010, Current drug metabolism.

[7]  Y. Peterson,et al.  Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions. , 2010, Toxicology.

[8]  Robert B. Parker,et al.  The Effect of Ethanol on Oral Cocaine Pharmacokinetics Reveals an Unrecognized Class of Ethanol-Mediated Drug Interactions , 2010, Drug Metabolism and Disposition.

[9]  Leon Poller,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[10]  T. Saitoh,et al.  Different Inhibitory Effects in Rat and Human Carboxylesterases , 2009, Drug Metabolism and Disposition.

[11]  K. Rathgen,et al.  Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment , 2008, Journal of clinical pharmacology.

[12]  T. Ebner,et al.  The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans , 2008, Drug Metabolism and Disposition.

[13]  K. Rathgen,et al.  The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. , 2007, British journal of clinical pharmacology.

[14]  A. Straughn,et al.  Influence of Ethanol and Gender on Methylphenidate Pharmacokinetics and Pharmacodynamics , 2007, Clinical pharmacology and therapeutics.

[15]  Jian Yang,et al.  Antiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl Alcohol , 2006, Journal of Pharmacology and Experimental Therapeutics.

[16]  Teruko Imai,et al.  Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine , 2006, Drug Metabolism and Disposition.

[17]  P. Taylor,et al.  Current progress on esterases: from molecular structure to function. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[18]  S. Laizure,et al.  Cocaethylene formation in rat, dog, and human hepatic microsomes. , 1999, Life sciences.

[19]  M. Mayersohn,et al.  Carboxylesterase-mediated transesterification of meperidine (Demerol) and methylphenidate (Ritalin) in the presence of [2H6]ethanol: preliminary in vitro findings using a rat liver preparation. , 1997, Journal of pharmaceutical sciences.

[20]  R. de la Torre,et al.  Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. , 1997, The Journal of pharmacology and experimental therapeutics.

[21]  J. Cashman,et al.  Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[22]  R. Harbison,et al.  Inhibition by ethanol of the metabolism of cocaine to benzoylecgonine and ecgonine methyl ester in mouse and human liver. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[23]  S. Laizure,et al.  Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism , 2012, Analytical and Bioanalytical Chemistry.

[24]  J. Stangier.  Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate , 2008, Clinical pharmacokinetics.

[25]  Teruko Imai,et al.  Human carboxylesterase isozymes: catalytic properties and rational drug design. , 2006, Drug metabolism and pharmacokinetics.

[26]  David M. Umulis,et al.  A physiologically based model for ethanol and acetaldehyde metabolism in human beings. , 2005, Alcohol.

[27]  S. Laizure,et al.  Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[28]  R. de la Torre,et al.  Cocaine metabolism in humans after use of alcohol. Clinical and research implications. , 1998, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.